Accent Microcell Ltd
Company Profile
Business description
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit) which generates maximum revenue, Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
Contact
Shyamal Cross Roads, Anandnagar Road
314, Shangrilla Arcade
Satellite
AhmedabadGJ380015
INDT: +91 7940042367
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
174
Stocks News & Analysis
stocks
Chart of the week: The top trades from SMSFs in 2024
stocks
Is this ASX share a long-term buy?
stocks
Why Guzman and Reece's share reversals have a lot in common
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,503.80 | 26.50 | 0.31% |
CAC 40 | 8,143.92 | 92.85 | 1.15% |
DAX 40 | 22,794.11 | 383.84 | 1.71% |
Dow JONES (US) | 43,433.12 | 188.04 | -0.43% |
FTSE 100 | 8,731.46 | 62.79 | 0.72% |
HKSE | 23,787.93 | 753.91 | 3.27% |
NASDAQ | 19,075.26 | 48.88 | 0.26% |
Nikkei 225 | 38,142.37 | 95.42 | -0.25% |
NZX 50 Index | 12,475.01 | 22.55 | 0.18% |
S&P 500 | 5,956.06 | 0.81 | 0.01% |
S&P/ASX 200 | 8,263.70 | 23.00 | 0.28% |
SSE Composite Index | 3,380.21 | 34.17 | 1.02% |